TRANDOLAPRIL — all Canadian products
44 DINs
31 marketed/approved
1 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TRANDOLAPRIL, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02487217 | APO-TRANDOLAPRIL | APOTEX INC | Capsule | Oral | TRANDOLAPRIL 4 MG | Approved | |
| 02487187 | APO-TRANDOLAPRIL | APOTEX INC | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Approved | |
| 02487195 | APO-TRANDOLAPRIL | APOTEX INC | Capsule | Oral | TRANDOLAPRIL 1 MG | Approved | |
| 02487209 | APO-TRANDOLAPRIL | APOTEX INC | Capsule | Oral | TRANDOLAPRIL 2 MG | Approved | |
| 02471868 | AURO-TRANDOLAPRIL | AURO PHARMA INC | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Marketed | |
| 02471892 | AURO-TRANDOLAPRIL | AURO PHARMA INC | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02471884 | AURO-TRANDOLAPRIL | AURO PHARMA INC | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02471876 | AURO-TRANDOLAPRIL | AURO PHARMA INC | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | |
| 02231460 | MAVIK | BGP PHARMA ULC | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02231457 | MAVIK | BGP PHARMA ULC | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Marketed | |
| 02231459 | MAVIK | BGP PHARMA ULC | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | |
| 02239267 | MAVIK | BGP PHARMA ULC | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02357771 | PMS-TRANDOLAPRIL | PHARMASCIENCE INC | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02357755 | PMS-TRANDOLAPRIL | PHARMASCIENCE INC | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Marketed | |
| 02357763 | PMS-TRANDOLAPRIL | PHARMASCIENCE INC | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | |
| 02357798 | PMS-TRANDOLAPRIL | PHARMASCIENCE INC | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02325721 | SANDOZ TRANDOLAPRIL | SANDOZ CANADA INCORPORATED | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Marketed | |
| 02325764 | SANDOZ TRANDOLAPRIL | SANDOZ CANADA INCORPORATED | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02325756 | SANDOZ TRANDOLAPRIL | SANDOZ CANADA INCORPORATED | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02325748 | SANDOZ TRANDOLAPRIL | SANDOZ CANADA INCORPORATED | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | |
| 02526581 | TRANDOLAPRIL | SIVEM PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02488671 | TRANDOLAPRIL | PRO DOC LIMITEE | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Approved | |
| 02488698 | TRANDOLAPRIL | PRO DOC LIMITEE | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | Yes |
| 02488701 | TRANDOLAPRIL | PRO DOC LIMITEE | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02488728 | TRANDOLAPRIL | PRO DOC LIMITEE | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02525038 | TRANDOLAPRIL | SANIS HEALTH INC | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Approved | |
| 02525046 | TRANDOLAPRIL | SANIS HEALTH INC | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | |
| 02525054 | TRANDOLAPRIL | SANIS HEALTH INC | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02525070 | TRANDOLAPRIL | SANIS HEALTH INC | Capsule | Oral | TRANDOLAPRIL 4 MG | Marketed | |
| 02526565 | TRANDOLAPRIL | SIVEM PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 1 MG | Marketed | |
| 02526573 | TRANDOLAPRIL | SIVEM PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 2 MG | Marketed | |
| 02471760 | MYLAN-TRANDOLAPRIL | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 1 MG | Cancelled Pre Market | |
| 02471779 | MYLAN-TRANDOLAPRIL | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 2 MG | Cancelled Pre Market | |
| 02471787 | MYLAN-TRANDOLAPRIL | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 4 MG | Cancelled Pre Market | |
| 02471752 | MYLAN-TRANDOLAPRIL | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Cancelled Pre Market | |
| 02240946 | TARKA | BGP PHARMA ULC | Tablet (Extended-Release) | Oral | TRANDOLAPRIL 2 MG; VERAPAMIL HYDROCHLORIDE 240 MG | Cancelled Post Market | |
| 02238097 | TARKA | BGP PHARMA ULC | Tablet (Extended-Release) | Oral | TRANDOLAPRIL 4 MG; VERAPAMIL HYDROCHLORIDE 240 MG | Cancelled Post Market | |
| 02238096 | TARKA | ABBOTT LABORATORIES, LIMITED | Tablet (Extended-Release) | Oral | TRANDOLAPRIL 2 MG; VERAPAMIL HYDROCHLORIDE 180 MG | Cancelled Post Market | |
| 02240945 | TARKA | ABBOTT LABORATORIES, LIMITED | Tablet (Extended-Release) | Oral | TRANDOLAPRIL 1 MG; VERAPAMIL HYDROCHLORIDE 240 MG | Cancelled Post Market | |
| 02415445 | TEVA-TRANDOLAPRIL | TEVA CANADA LIMITED | Capsule | Oral | TRANDOLAPRIL 2 MG | Cancelled Post Market | |
| 02415437 | TEVA-TRANDOLAPRIL | TEVA CANADA LIMITED | Capsule | Oral | TRANDOLAPRIL 1 MG | Cancelled Post Market | |
| 02415429 | TEVA-TRANDOLAPRIL | TEVA CANADA LIMITED | Capsule | Oral | TRANDOLAPRIL 0.5 MG | Cancelled Post Market | |
| 02415453 | TEVA-TRANDOLAPRIL | TEVA CANADA LIMITED | Capsule | Oral | TRANDOLAPRIL 4 MG | Cancelled Post Market | |
| 02384507 | TRANDOLAPRIL | LABORATOIRE RIVA INC. | Capsule | Oral | TRANDOLAPRIL 2 MG | Cancelled Post Market |
Browse other molecules: